Organised mammographic screening programmes

Dr Philippe Autier – International Prevention Research Institute, Lyon, France
Organised mammographic screening programmes ( Dr Philippe Autier – International Prevention Research Institute, Lyon, France )
23 Jul 2012

Global burden of breast cancer

Ambassador Nancy Brinker - Founder of Susan G Komen for the Cure
Global burden of breast cancer ( Ambassador Nancy Brinker - Founder of Susan G Komen for the Cure )
21 Jul 2012

The impact of breast cancer in Africa

Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria
The impact of breast cancer in Africa ( Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria )
20 Jul 2012

Combining the Red Ribbon, HIV, and Pink Ribbon, breast cancer, campaigns

Brian Hook – Pink Ribbon Red Ribbon Partnership
Combining the Red Ribbon, HIV, and Pink Ribbon, breast cancer, campaigns ( Brian Hook – Pink Ribbon Red Ribbon Partnership )
20 Jul 2012

Future direction for breast cancer treatment

Prof Michael Baum - University College London, UK
Future direction for breast cancer treatment ( Prof Michael Baum - University College London, UK )
20 Jul 2012

Circulating metastasis-initiating cells in breast cancer

Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
Circulating metastasis-initiating cells in breast cancer ( Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany )
19 Jul 2012

Underlying metabolic pathways in cancer

Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain
Underlying metabolic pathways in cancer ( Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain )
18 Jul 2012

Understanding the mechanisms of breast cancer resistance

Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
Understanding the mechanisms of breast cancer resistance ( Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jul 2012

Epigenetics of cancer and changes in DNA modification in tumours

Prof Manel Esteller – University of Barcelona, Catalonia, Spain
Epigenetics of cancer and changes in DNA modification in tumours  ( Prof Manel Esteller – University of Barcelona, Catalonia, Spain   )
16 Jul 2012

Importance of early detection and the ‘Beyond the Shock’ programme

Dr Douglas Feil – National Breast Cancer Foundation, USA
Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )
6 Jul 2012

BRCA carrier status as a prognostic factor for prostate cancer

Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )
19 Jun 2012